Cargando…
A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy
Metabolic adaptation is considered an emerging hallmark of cancer, whereby cancer cells exhibit high rates of glucose consumption with consequent lactate production. To ensure rapid efflux of lactate, most cancer cells express high levels of monocarboxylate transporters (MCTs), which therefore may c...
Autores principales: | Pertega‐Gomes, Nelma, Felisbino, Sergio, Massie, Charlie E, Vizcaino, Jose R, Coelho, Ricardo, Sandi, Chiranjeevi, Simoes‐Sousa, Susana, Jurmeister, Sarah, Ramos‐Montoya, Antonio, Asim, Mohammad, Tran, Maxine, Oliveira, Elsa, Lobo da Cunha, Alexandre, Maximo, Valdemar, Baltazar, Fatima, Neal, David E, Fryer, Lee GD |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528232/ https://www.ncbi.nlm.nih.gov/pubmed/25875424 http://dx.doi.org/10.1002/path.4547 |
Ejemplares similares
-
Clinical impact of the metabolic phenotype of prostate cancer: role of monocarboxylate transporters (MCTs)
por: Pértega-Gomes, Nelma, et al.
Publicado: (2013) -
Identification of potential therapeutic targets in prostate cancer through a cross‐species approach
por: Jurmeister, Sarah, et al.
Publicado: (2018) -
A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer
por: Pértega-Gomes, Nelma, et al.
Publicado: (2014) -
Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer
por: Pértega-Gomes, Nelma, et al.
Publicado: (2011) -
Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer
por: Pertega-Gomes, Nelma, et al.
Publicado: (2015)